Condition
Chronic Kidney Disease(CKD) clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Chronic Kidney Disease(CKD) clinical trials that are recruiting, at sites in 13 countries (most in United States (5), China (3), Denmark (3)). By phase: Phase 2 (3), Phase 4 (1), Phase 3 (1), Phase 1 (1). The most active sponsors are Hacettepe University (3), Odense University Hospital (2), Duke University (2). There are also 3 NIH-funded research projects on Chronic Kidney Disease(CKD), with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 3NIH research projects
- 13Countries
Newest Chronic Kidney Disease(CKD) clinical trials
All recruiting trials (21)
-
Biomarker-guided treatment strategy for chronic kidney disease
This trial will test whether using urine biomarkers to guide adding dapagliflozin, finerenone, and/or semaglutide can better reduce albuminuria and protect kidneys in adults with CKD.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Heart, kidney, and metabolic health in Shanghai community residents
This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.
-
Safety, tolerability, and how the body handles SK-08 in healthy adults
This will test whether SK-08 is safe, well tolerated, and how the body processes it in healthy adults aged 18–45.
-
How common high potassium is and what increases the risk in non-dialysis CKD patients in the community
This project will test how common high potassium is and try to find which health and lifestyle factors raise the risk in adults with chronic kidney disease who are not on dialysis.
-
Using a plant-based low protein diet to manage chronic kidney disease
This study is testing if a plant-based low protein diet can help people with chronic kidney disease manage their condition better than a standard diet.
-
Effects of Amiloride on Chronic Kidney Disease Progression
This study is testing if the medication amiloride can help people with chronic kidney disease by protecting their kidneys and reducing protein in their urine without changing their blood pressure.
-
IRIS-CKD Program 2: Improving screening and management for chronic kidney disease in people with type 2 diabetes
This program will test whether a guided management program (plus education) helps doctors prescribe recommended CKD medicines for adults with type 2 diabetes and lab evidence of kidney disease.
-
Improving kidney disease screening for adults with type 2 diabetes
This program will test whether mailing home urine/blood test kits or giving a standard lab order helps adults with type 2 diabetes complete recommended kidney screening.
-
Using Dapagliflozin to Treat Anemia in Patients with Chronic Kidney Disease
This study is testing if the diabetes medication dapagliflozin can help raise hemoglobin levels in adults with chronic kidney disease and anemia who are already on other treatments.
-
Using Camostat to Protect Kidneys in Chronic Kidney Disease
This study is testing if a medication called Camostat can help protect the kidneys and improve health in people with chronic kidney disease.
-
Using MRI to study kidney disease and its complications
This study is testing if a special type of MRI can help find out more about kidney problems and their effects on heart health in people with acute kidney injury and chronic kidney disease.
-
Monocyte responses in adults with type 1 diabetes and chronic kidney disease
This study will test whether time-in-range changes how monocytes become activated in adults with type 1 diabetes and chronic kidney disease and whether a GLP-1 drug can reduce that activation in lab tests.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Assessing functional capacity in children with chronic kidney disease
This study tests how chronic kidney disease affects the everyday physical abilities of children aged 6 to 18.
-
Assessing cardiovascular risk knowledge in chronic kidney disease patients
This study is trying to see how well people with chronic kidney disease understand heart health risks compared to healthy people, while also looking at their exercise habits and knowledge about staying active.
-
Epicatechin for muscle fat and weakness in advanced chronic kidney disease
This study will give 100 mg/day of the nutraceutical epicatechin for 8 weeks to people with advanced CKD to see if it increases muscle mass, reduces fat in muscle, and improves strength.
-
Understanding kidney disease in people with cystic fibrosis
This study looks at how cystic fibrosis affects kidney health by checking blood and urine samples to help find ways to spot and prevent kidney problems early.
-
Evaluating the BETY-BQ Questionnaire for Chronic Kidney Disease and Transplant Patients
This study is testing a new questionnaire to see how well it helps understand the challenges faced by people with chronic kidney disease, those on dialysis, and kidney transplant patients.
-
Improving blood pressure management in patients with chronic kidney disease
This study tests if a stronger approach to lowering blood pressure using diuretics can help people with chronic kidney disease and high blood pressure feel better and stay healthier.
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
How FGF23 hormone fragments affect kidney disease, anemia, and heart health
This project explores whether different fragments of the hormone FGF23 made by bone and blood change iron levels, anemia, and heart risk in people with chronic kidney disease.
-
Racial and ethnic disparities in kidney disease progression and onset
Aimed at understanding why Black adults with or at risk for chronic kidney disease experience different outcomes and onset ages compared with other groups.
-
Investigating the role of FGF23 peptides in chronic kidney disease
This study is looking at how a hormone called FGF23, which comes from your bones, affects people with chronic kidney disease (CKD) and aims to find better ways to treat related health problems like heart issues and anemia.
Related topics
Quick answers
How many Chronic Kidney Disease(CKD) clinical trials are recruiting right now?
21, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (5 trials), China (3 trials), Denmark (3 trials), Turkey (Türkiye) (3 trials), Sweden (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.